Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA Completes Inspection of NATCO''s Kothur Formulation Facility06-03-2020
06-03-2020
Earnings Call Transcript - Natco Pharma
Full Earnings Transcript: Conference Call between Management and Analysts20-02-2020
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q3 FY 2019-202015-02-2020
Natco Pharma Q3 net down 34.5% at 104 crore
Natco Pharma Ltd's consolidated net profit declined 34.5 per cent at 104 crore in the third quarter ended December 31, 2019 compared to 159 crore i12-02-2020
Natco Pharma Ltd - 524816 - Record Date 25Th February, 2020
25th February, 2020 has been fixed as Record Date for making payment of 3rd Interim Dividend for the FY 2019-202012-02-2020
Natco Pharma Ltd - 524816 - Corporate Action-Board approves Dividend
The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim Dividend of Rs.3.50 per Equity share of Rs.2/- each for the FY 2019-202012-02-2020
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q3FY20 Earnings Call on 13th February, 202010-02-2020
NATCO PHARMA LTD. - 524816 - Board to consider FY19 results & Third Interim Dividend on Feb 12, 2020
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 12, 2020, inter alia, to consider the following items of business:1. Approval of the unaudited financial results, both on standalone and consolidated basis for the quarter ended December 31, 2019 and related matters.2. To consider third Interim Dividend, if any, for the financial year 2019-20 and related matters etc. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time TRADING WINDOW for dealing in the securities of the Company by the Employee(s) and their immediate relatives will be closed fromFebruary 04, 2020 to February 14, 2020 (both days inclusive). Trading window will be re-opened on February 17, 2020.03-02-2020
Natco Pharma Ltd - 524816 - Board Meeting Intimation for Notice Of Board Meeting
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve 1. Approval of the unaudited financial results, both on standalone and consolidated basis for the quarter ended 31st December, 2019 and related matters. 2. To consider third Interim Dividend, if any, for the financial year 2019-20 and related matters etc.03-02-2020